06.05.2016 17:13:01
|
DGAP-Stimmrechtsanteile: WILEX AG
WILEX AG
06.05.2016 17:13
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Notification of Major Holdings
1. Details of issuer
WILEX AG
Grillparzerstr. 18
81675 München
Germany
2. Reason for notification
X Acquisition/disposal of shares with voting rights
Acquisition/disposal of instruments
X Change of breakdown of voting rights
X Other reason: Volontary Group announcement for change in threshold
at the level of a subsidiary
3. Details of person subject to the notification obligation
Name: City and country of registered office: Mr Dietmar Hopp Germany
4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.
Curacyte GmbH dievini Hopp BioTech holding GmbH & Co. KG DH-Holding Verwaltungs GmbH
5. Date on which threshold was crossed or reached
27 Apr 2016
6. Total positions
% of voting % of voting rights total of total number rights attached through instruments both in % of voting to shares (total (total of 7.b.1 + (7.a. + rights of of 7.a.) 7.b.2) 7.b.) issuer Result- 63.53 % 0.00 % 63.53 % 12927564 ing situat- ion Previo- 51.67 % n/a % n/a % / us notifi- cation
7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 21, 22 WpHG)
ISIN absolute in % direct (Sec. indirect (Sec. direct (Sec. indirect 21 WpHG) 22 WpHG) 21 WpHG) (Sec. 22 WpHG) DE000A11QVV0 171538 8041226 1.33 % 62.20 % Total 8212764 63.53 %
b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG
Type of Expiration or Exercise or Voting Voting instrument maturity date conversion rights rights in period absolute % % Total %
b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG
Type of Expiration Exercise or Cash or Voting Voting instrume- or maturity conversion physical rights rights nt date period settlement absolute in % % Total %
8. Information in relation to the person subject to the notification obligation
Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:
Name % of voting % of voting rights Total of both rights (if at through instruments (if (if at least least held 3% or at least held 5% or held 5% or more) more) more) Herr Dietmar - % - % - % Hopp DH-Holding - % - % - % GmbH & Co. KG DH-Holding 7.24 % - % 7.24 % Verwaltungs GmbH Zurechnungsstr- % % % ang 2 Herr Dietmar - % - % - % Hopp DH-Holding - % - % - % GmbH & Co. KG DH-Capital - % - % - % GmbH & Co. KG dievini Hopp 50.52 % - % 50.52 % BioTech holding GmbH & Co. KG Curacyte GmbH 4.44 % - % - %
9. In case of proxy voting according to Sec. 22 para. 3 WpHG
Date of general meeting: Holding position after general meeting: % (equals voting rights)
06.05.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
--------------------------------------------------------------------------- Language: English Company: WILEX AG Grillparzerstr. 18 81675 München Germany Internet: www.wilex.com End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Heidelberg Pharma AGmehr Nachrichten
Analysen zu Heidelberg Pharma AGmehr Analysen
Aktien in diesem Artikel
Heidelberg Pharma AG | 2,42 | 0,00% |